Application of Iced Normal Saline Combined With Cocktail Perfusion in Total Knee Arthroplasty
NCT ID: NCT05204056
Last Updated: 2022-01-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2018-03-02
2018-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Efficacy and Safety of Using Tranexamic Acid to Reduce Blood Loss In Simultaneous Bilateral Total Knee Arthroplasty
NCT02504125
Tranexamic Acid for Total Knee Arthroscopy
NCT04443920
Intravenous Versus Topical Administration of Low Dose Epinephrine Plus Combined Administration of Intravenous and Topical Tranexamic Acid (TXA)for Primary Total Knee Arthroplasty
NCT02860221
Evaluation of Intraarticular Tranexamic Acid to Reduction of Total Blood Loss Following Knee-Arthroplasty
NCT02427412
Study on BT-114143 Reducing Perioperative Bleeding in Total Knee Arthroplasty(TKA)
NCT07127042
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
Twenty patients who were given intraoperative joint cavity infusion therapy using 20ml tranexamic and 40ml iced normal saline.
iced normal saline
Iced normal saline (20ml) was given intraoperative joint cavity infusion therapy
Tranexamic acid injection
20ml of tranexamic was given with iced normal saline for intraoperative joint cavity infusion.
Group B
Twenty patients who were given 20ml of iced normal saline, 20ml of iced cocktail and 20ml of tranexamic
iced normal saline
Iced normal saline (20ml) was given intraoperative joint cavity infusion therapy
Tranexamic acid injection
20ml of tranexamic was given with iced normal saline for intraoperative joint cavity infusion.
Cocktail (composing by Ropivacaine, Morphine and Epinephrine) perfusion
Cocktail was formulated during the operation by mixing Ropivacaine 150mg, Morphine 10mg and Epinephrine 1mg, then normal saline was used to dilute the mixture to 60ml. Then the cocktail mixture was applied for the joint cavity perfusion.
Control group
Twenty patients were given joint cavity infusion therapy with 20ml tranexamic only as the control group
Tranexamic acid injection
20ml of tranexamic was given with iced normal saline for intraoperative joint cavity infusion.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
iced normal saline
Iced normal saline (20ml) was given intraoperative joint cavity infusion therapy
Tranexamic acid injection
20ml of tranexamic was given with iced normal saline for intraoperative joint cavity infusion.
Cocktail (composing by Ropivacaine, Morphine and Epinephrine) perfusion
Cocktail was formulated during the operation by mixing Ropivacaine 150mg, Morphine 10mg and Epinephrine 1mg, then normal saline was used to dilute the mixture to 60ml. Then the cocktail mixture was applied for the joint cavity perfusion.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yantai Yuhuangding Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laijian Sui, Doctor
Role: STUDY_CHAIR
Yantai Yuhuangding Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yantai Yuhuangding Hospital
Yantai, Shandong, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-149
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.